APO Research
Talk to an analyst

APO RESEARCH · REPORT

Companion Animal Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Companion Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025180 pages

Choose your research edition.

Industry ResearchCompanion Animal Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Companion Animal Vaccines Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Companion Animal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Companion Animal Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Companion Animal Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Companion Animal Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Companion Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Companion Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Companion Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Companion Animal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Companion Animal Vaccines include Merck, Eli Lilly, Bayer, Vetoquinol, Merial, Heska, Ceva and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Companion Animal Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Companion Animal Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Companion Animal Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Companion Animal Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Companion Animal Vaccines Segment by Company

Merck

Eli Lilly

Bayer

Vetoquinol

Merial

Heska

Ceva

Boehringer Ingelheim

Companion Animal Vaccines Segment by Type

Recombinant Vaccines

Subunit Vaccines

Inactivated Vaccines

Toxoid Vaccines

Conjugate Vaccines

Attenuated Live Vaccines

DNA Vaccines

Companion Animal Vaccines Segment by Application

Canine

Avian

Feline

Companion Animal Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Companion Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Companion Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Companion Animal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Companion Animal Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Companion Animal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Companion Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Companion Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Companion Animal Vaccines Industry Trends Table 2. Companion Animal Vaccines Industry Drivers Table 3. Companion Animal Vaccines Industry Opportunities and Challenges Table 4. Companion Animal Vaccines Industry Restraints Table 5. Global Companion Animal Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Companion Animal Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Companion Animal Vaccines Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Companion Animal Vaccines Sales Market Share by Manufacturers Table 9. Global Companion Animal Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Companion Animal Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Companion Animal Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Companion Animal Vaccines Manufacturers, Product Type & Application Table 13. Global Companion Animal Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Companion Animal Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Recombinant Vaccines Table 17. Major Manufacturers of Subunit Vaccines Table 18. Major Manufacturers of Inactivated Vaccines Table 19. Major Manufacturers of Toxoid Vaccines Table 20. Major Manufacturers of Conjugate Vaccines Table 21. Major Manufacturers of Attenuated Live Vaccines Table 22. Major Manufacturers of DNA Vaccines Table 23. Global Companion Animal Vaccines Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Companion Animal Vaccines Sales by Type (2021-2026) & (W Units) Table 25. Global Companion Animal Vaccines Sales by Type (2027-2032) & (W Units) Table 26. Global Companion Animal Vaccines Sales Market Share by Type (2021-2026) Table 27. Global Companion Animal Vaccines Sales Market Share by Type (2027-2032) Table 28. Global Companion Animal Vaccines Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 29. Global Companion Animal Vaccines Revenue by Type (2021-2026) & (W Units) Table 30. Global Companion Animal Vaccines Revenue by Type (2027-2032) & (W Units) Table 31. Global Companion Animal Vaccines Revenue Market Share by Type (2021-2026) Table 32. Global Companion Animal Vaccines Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Canine Table 34. Major Manufacturers of Avian Table 35. Major Manufacturers of Feline Table 36. Global Companion Animal Vaccines Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Companion Animal Vaccines Sales by Application (2021-2026) & (W Units) Table 38. Global Companion Animal Vaccines Sales by Application (2027-2032) & (W Units) Table 39. Global Companion Animal Vaccines Sales Market Share by Application (2021-2026) Table 40. Global Companion Animal Vaccines Sales Market Share by Application (2027-2032) Table 41. Global Companion Animal Vaccines Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global Companion Animal Vaccines Revenue by Application (2021-2026) & (W Units) Table 43. Global Companion Animal Vaccines Revenue by Application (2027-2032) & (W Units) Table 44. Global Companion Animal Vaccines Revenue Market Share by Application (2021-2026) Table 45. Global Companion Animal Vaccines Revenue Market Share by Application (2027-2032) Table 46. Global Companion Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Companion Animal Vaccines Sales by Region (2021-2026) & (W Units) Table 48. Global Companion Animal Vaccines Sales Market Share by Region (2021-2026) Table 49. Global Companion Animal Vaccines Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global Companion Animal Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Companion Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 53. North America Companion Animal Vaccines Sales by Country (2027-2032) & (W Units) Table 54. Europe Companion Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 56. Europe Companion Animal Vaccines Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific Companion Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific Companion Animal Vaccines Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa Companion Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa Companion Animal Vaccines Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa Companion Animal Vaccines Sales by Country (2027-2032) & (W Units) Table 63. Global Companion Animal Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Companion Animal Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Companion Animal Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Companion Animal Vaccines Revenue Market Share by Region (2021-2026) Table 67. Global Companion Animal Vaccines Revenue Market Share by Region (2027-2032) Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Companion Animal Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck Companion Animal Vaccines Product Portfolio Table 72. Merck Recent Development Table 73. Eli Lilly Company Information Table 74. Eli Lilly Business Overview Table 75. Eli Lilly Companion Animal Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Eli Lilly Companion Animal Vaccines Product Portfolio Table 77. Eli Lilly Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Companion Animal Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bayer Companion Animal Vaccines Product Portfolio Table 82. Bayer Recent Development Table 83. Vetoquinol Company Information Table 84. Vetoquinol Business Overview Table 85. Vetoquinol Companion Animal Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Vetoquinol Companion Animal Vaccines Product Portfolio Table 87. Vetoquinol Recent Development Table 88. Merial Company Information Table 89. Merial Business Overview Table 90. Merial Companion Animal Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Merial Companion Animal Vaccines Product Portfolio Table 92. Merial Recent Development Table 93. Heska Company Information Table 94. Heska Business Overview Table 95. Heska Companion Animal Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Heska Companion Animal Vaccines Product Portfolio Table 97. Heska Recent Development Table 98. Ceva Company Information Table 99. Ceva Business Overview Table 100. Ceva Companion Animal Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Ceva Companion Animal Vaccines Product Portfolio Table 102. Ceva Recent Development Table 103. Boehringer Ingelheim Company Information Table 104. Boehringer Ingelheim Business Overview Table 105. Boehringer Ingelheim Companion Animal Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Boehringer Ingelheim Companion Animal Vaccines Product Portfolio Table 107. Boehringer Ingelheim Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Companion Animal Vaccines Distributors List Table 111. Companion Animal Vaccines Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Companion Animal Vaccines Product Image Figure 2. Global Companion Animal Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Companion Animal Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Companion Animal Vaccines Sales (2021-2032) & (W Units) Figure 5. Global Companion Animal Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Companion Animal Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Recombinant Vaccines Image Figure 9. Subunit Vaccines Image Figure 10. Inactivated Vaccines Image Figure 11. Toxoid Vaccines Image Figure 12. Conjugate Vaccines Image Figure 13. Attenuated Live Vaccines Image Figure 14. DNA Vaccines Image Figure 15. Global Companion Animal Vaccines Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 16. Global Companion Animal Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Companion Animal Vaccines Sales Market Share by Type (2021-2032) Figure 18. Global Companion Animal Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 19. Global Companion Animal Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Companion Animal Vaccines Revenue Market Share by Type (2021-2032) Figure 21. Canine Image Figure 22. Avian Image Figure 23. Feline Image Figure 24. Global Companion Animal Vaccines Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Companion Animal Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Companion Animal Vaccines Sales Market Share by Application (2021-2032) Figure 27. Global Companion Animal Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global Companion Animal Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Companion Animal Vaccines Revenue Market Share by Application (2021-2032) Figure 30. North America Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America Companion Animal Vaccines Sales Market Share by Country (2021-2032) Figure 32. U.S. Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Companion Animal Vaccines Sales Market Share by Country (2021-2032) Figure 37. Germany Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Companion Animal Vaccines Sales Market Share by Country (2021-2032) Figure 44. China Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Companion Animal Vaccines Sales Market Share by Country (2021-2032) Figure 52. Brazil Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile Companion Animal Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global Companion Animal Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Companion Animal Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. North America Companion Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 65. Europe Companion Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Companion Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Companion Animal Vaccines Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Companion Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Companion Animal Vaccines Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Companion Animal Vaccines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Subunit Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Attenuated Live Vaccines
  • DNA Vaccines
Applications
  • Canine
  • Avian
  • Feline
Companies covered
  • Merck
  • Eli Lilly
  • Bayer
  • Vetoquinol
  • Merial
  • Heska
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Companion Animal Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Companion Animal Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Companion Animal Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Companion Animal Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Companion Animal Vaccines Market Dynamics
  1. 2.1 Companion Animal Vaccines Industry Trends
  2. 2.2 Companion Animal Vaccines Industry Drivers
  3. 2.3 Companion Animal Vaccines Industry Opportunities and Challenges
  4. 2.4 Companion Animal Vaccines Industry Restraints
3 Companion Animal Vaccines Market by Manufacturers
  1. 3.1 Global Companion Animal Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Companion Animal Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Companion Animal Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Companion Animal Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Companion Animal Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Companion Animal Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Companion Animal Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Companion Animal Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Companion Animal Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Companion Animal Vaccines Tier 1, Tier 2, and Tier 3
4 Companion Animal Vaccines Market by Type
  1. 4.1 Companion Animal Vaccines Type Introduction
  2. 4.1.1 Recombinant Vaccines
  3. 4.1.2 Subunit Vaccines
  4. 4.1.3 Inactivated Vaccines
  5. 4.1.4 Toxoid Vaccines
  6. 4.1.5 Conjugate Vaccines
  7. 4.1.6 Attenuated Live Vaccines
  8. 4.1.7 DNA Vaccines
  9. 4.2 Global Companion Animal Vaccines Sales by Type
  10. 4.2.1 Global Companion Animal Vaccines Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Companion Animal Vaccines Sales by Type (2021-2032)
  12. 4.2.3 Global Companion Animal Vaccines Sales Market Share by Type (2021-2032)
  13. 4.3 Global Companion Animal Vaccines Revenue by Type
  14. 4.3.1 Global Companion Animal Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Companion Animal Vaccines Revenue by Type (2021-2032)
  16. 4.3.3 Global Companion Animal Vaccines Revenue Market Share by Type (2021-2032)
5 Companion Animal Vaccines Market by Application
  1. 5.1 Companion Animal Vaccines Application Introduction
  2. 5.1.1 Canine
  3. 5.1.2 Avian
  4. 5.1.3 Feline
  5. 5.2 Global Companion Animal Vaccines Sales by Application
  6. 5.2.1 Global Companion Animal Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Companion Animal Vaccines Sales by Application (2021-2032)
  8. 5.2.3 Global Companion Animal Vaccines Sales Market Share by Application (2021-2032)
  9. 5.3 Global Companion Animal Vaccines Revenue by Application
  10. 5.3.1 Global Companion Animal Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Companion Animal Vaccines Revenue by Application (2021-2032)
  12. 5.3.3 Global Companion Animal Vaccines Revenue Market Share by Application (2021-2032)
6 Global Companion Animal Vaccines Sales by Region
  1. 6.1 Global Companion Animal Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Companion Animal Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Companion Animal Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Companion Animal Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Companion Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Companion Animal Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Companion Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Companion Animal Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Companion Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Companion Animal Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Companion Animal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Companion Animal Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Companion Animal Vaccines Revenue by Region
  1. 7.1 Global Companion Animal Vaccines Revenue by Region
  2. 7.1.1 Global Companion Animal Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Companion Animal Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Companion Animal Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Companion Animal Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Companion Animal Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Companion Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Companion Animal Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Companion Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Companion Animal Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Companion Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Companion Animal Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Companion Animal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Companion Animal Vaccines Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Companion Animal Vaccines Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Companion Animal Vaccines Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Vetoquinol
  20. 8.4.1 Vetoquinol Company Information
  21. 8.4.2 Vetoquinol Business Overview
  22. 8.4.3 Vetoquinol Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vetoquinol Companion Animal Vaccines Product Portfolio
  24. 8.4.5 Vetoquinol Recent Developments
  25. 8.5 Merial
  26. 8.5.1 Merial Company Information
  27. 8.5.2 Merial Business Overview
  28. 8.5.3 Merial Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merial Companion Animal Vaccines Product Portfolio
  30. 8.5.5 Merial Recent Developments
  31. 8.6 Heska
  32. 8.6.1 Heska Company Information
  33. 8.6.2 Heska Business Overview
  34. 8.6.3 Heska Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Heska Companion Animal Vaccines Product Portfolio
  36. 8.6.5 Heska Recent Developments
  37. 8.7 Ceva
  38. 8.7.1 Ceva Company Information
  39. 8.7.2 Ceva Business Overview
  40. 8.7.3 Ceva Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ceva Companion Animal Vaccines Product Portfolio
  42. 8.7.5 Ceva Recent Developments
  43. 8.8 Boehringer Ingelheim
  44. 8.8.1 Boehringer Ingelheim Company Information
  45. 8.8.2 Boehringer Ingelheim Business Overview
  46. 8.8.3 Boehringer Ingelheim Companion Animal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boehringer Ingelheim Companion Animal Vaccines Product Portfolio
  48. 8.8.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Companion Animal Vaccines Value Chain Analysis
  2. 9.1.1 Companion Animal Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Companion Animal Vaccines Production Mode & Process
  6. 9.2 Companion Animal Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Companion Animal Vaccines Distributors
  9. 9.2.3 Companion Animal Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst